|
|
Blood, 1 January 2005, Vol. 105, No. 1, pp. 282-288.
Prepublished online as a Blood First Edition Paper on September 2, 2004; DOI 10.1182/blood-2004-07-2782.
Previous Article | Next Article 
Submitted July 21, 2004
Accepted August 22, 2004
Stabilization of IFN- mRNA by MAPK p38 in IL-12- and IL-18-stimulated human NK cells
Athanasios Mavropoulos, Gareth Sully, Andrew P Cope, and Andrew R Clark*
Kennedy Institute of Rheumatology Division, Imperial College London, London, United Kingdom
* Corresponding author; email: andy.clark{at}imperial.ac.uk.
The rapid induction of IFN- by innate cytokines such as IL-12 and IL-18 is critical for immunity against infectious pathogens. We investigated the molecular mechanisms underlying this response. IL-12 and IL-18 rapidly and synergistically induced the secretion of IFN- by freshly purified human peripheral blood lymphocytes. At early time points IFN- was expressed almost exclusively by natural killer cells, and in both CD56bright and CD56dim sub-populations. Mitogen activated protein kinase p38 was activated strongly by IL-18 and weakly by IL-12 in natural killer cells, but was not activated by either cytokine in T cells. The expression of IFN- mRNA and protein was dose-dependently blocked by SB203580, a specific inhibitor of mitogen activated protein kinase p38, which also caused a dramatic destabilization of IFN- mRNA. The 3' untranslated region of IFN- mRNA conferred p38-responsiveness to a heterologous reporter mRNA. Therefore the synergistic induction of IFN- by IL-12 and IL-18 in natural killer cells is mediated at least in part by p38-dependent and 3' UTR-mediated stabilization of IFN- mRNA.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
O. Gross, C. Grupp, C. Steinberg, S. Zimmermann, D. Strasser, N. Hannesschlager, W. Reindl, H. Jonsson, H. Huo, D. R. Littman, et al.
Multiple ITAM-coupled NK-cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-{kappa}B and MAPK activation to selectively control cytokine production
Blood,
September 15, 2008;
112(6):
2421 - 2428.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Athie-Morales, G. M. O'Connor, and C. M. Gardiner
Activation of Human NK Cells by the Bacterial Pathogen-Associated Molecular Pattern Muramyl Dipeptide
J. Immunol.,
March 15, 2008;
180(6):
4082 - 4089.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Schierloh, N. Yokobori, M. Aleman, V. Landoni, L. Geffner, R. M. Musella, J. Castagnino, M. Baldini, E. Abbate, S. S. de la Barrera, et al.
Mycobacterium tuberculosis-Induced Gamma Interferon Production by Natural Killer Cells Requires Cross Talk with Antigen-Presenting Cells Involving Toll-Like Receptors 2 and 4 and the Mannose Receptor in Tuberculous Pleurisy
Infect. Immun.,
November 1, 2007;
75(11):
5325 - 5337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Abraham, T. Lawrence, A. Kleiman, P. Warden, M. Medghalchi, J. Tuckermann, J. Saklatvala, and A. R. Clark
Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1
J. Exp. Med.,
August 7, 2006;
203(8):
1883 - 1889.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. S. Berenson, J. Yang, B. P. Sleckman, T. L. Murphy, and K. M. Murphy
Selective Requirement of p38{alpha} MAPK in Cytokine-Dependent, but Not Antigen Receptor-Dependent, Th1 Responses.
J. Immunol.,
April 15, 2006;
176(8):
4616 - 4621.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Luyendyk, L. D. Lehman-McKeeman, D. M. Nelson, V. M. Bhaskaran, T. P. Reilly, B. D. Car, G. H. Cantor, J. F. Maddox, P. E. Ganey, and R. A. Roth
Unique Gene Expression and Hepatocellular Injury in the Lipopolysaccharide-Ranitidine Drug Idiosyncrasy Rat Model: Comparison with Famotidine
Toxicol. Sci.,
April 1, 2006;
90(2):
569 - 585.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-S. Chang, J. F. Huggett, K. Dheda, L. U. Kim, A. Zumla, and G. A. W. Rook
Myobacterium tuberculosis Induces Selective Up-Regulation of TLRs in the Mononuclear Leukocytes of Patients with Active Pulmonary Tuberculosis.
J. Immunol.,
March 1, 2006;
176(5):
3010 - 3018.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|